Yes, because the patient and caregiver consent, the patient has no known variant and complete clinical response


Start complement inhibition (eculizumab/ravulizumab)

Map: TMA (792)
Node: 16364
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Yes, because the patient and caregiver consent, the patient has no known variant and complete clinical response

Reminder

FINISH

Time is up